For the year ending 2025-12-31, AMWL had -$45,988K decrease in cash & cash equivalents over the period. -$65,974K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net loss | -94,967 |
| Goodwill impairment | 0 |
| Investment impairment | 1,000 |
| Depreciation and amortization expense | 33,960 |
| Provisions for credit losses | 2,744 |
| Inventory provisions | 500 |
| Net gain on divestiture | 8,634 |
| Amortization of deferred contract acquisition costs | 2,623 |
| Amortization of deferred contract fulfillment costs | 1,020 |
| Accretion of discounts on debt securities | 0 |
| Interest on debt securities | 0 |
| Stock-based compensation expense | 22,010 |
| Loss on equity method investment | -1,696 |
| Deferred income taxes | -1,110 |
| Accounts receivable | -12,220 |
| Inventories | -1,171 |
| Deferred contract acquisition costs | 1,800 |
| Prepaid expenses and other current assets | -871 |
| Other assets | -779 |
| Accounts payable | -3,418 |
| Accrued expenses and other current liabilities | -3,642 |
| Deferred revenue | -32,976 |
| Net cash used in operating activities | -65,953 |
| Purchases of property and equipment | 21 |
| Capitalized software development costs | 0 |
| Investment in less than majority owned joint venture | 196 |
| Net proceeds from divestiture | 18,321 |
| Purchases of investments | 1,000 |
| Proceeds from sales and maturities of investments | 0 |
| Net cash provided by (used in) investing activities | 17,104 |
| Proceeds from exercise of common stock options | 0 |
| Proceeds from employee stock purchase plan | 844 |
| Payments for the purchase of treasury stock | 4 |
| Net cash provided by financing activities | 840 |
| Effect of exchange rates changes on cash, cash equivalents, and restricted cash | 2,021 |
| Net decrease in cash, cash equivalents, and restricted cash | -45,988 |
| Cash and cash equivalents at beginning of period | 229,111 |
| Cash and cash equivalents at end of period | 183,123 |
American Well Corp (AMWL)
American Well Corp (AMWL)